Frequency-velocity mismatch: A fundamental abnormality in parkinsonian gait

Journal of Neurophysiology

Volumn 103, Issue 3, 2010, Pages 1478-1489

  Cho, Catherine ^a   Kunin, Mikhail ^b   Kudo, Koji ^a,d   Osaki, Yasuhiro ^c   Olanow, C Warren ^a   Cohen, Bernard ^a   Raphan, Theodore ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DYSKINESIA; FEEDBACK SYSTEM; FEMALE; FOOT; GAIT; GAIT DISORDER; HUMAN; INSTRUMENT; KINEMATICS; LEG MOVEMENT; MALE; MOTION ANALYSIS SYSTEM; MUSCLE RIGIDITY; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TREADMILL EXERCISE; UNIFIED PARKINSON DISEASE RATING SCALE; VELOCITY; WALKING SPEED;

ACOUSTIC STIMULATION; AGED; ALGORITHMS; ANTIPARKINSON AGENTS; BIOMECHANICS; FEEDBACK, PHYSIOLOGICAL; FEMALE; FOOT; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; MOVEMENT; PARKINSONIAN DISORDERS; WALKING;

EID: 77949702387     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00664.2009     Document Type: Article

References (51)

1. Arias P, Cudeiro J. Effects of rhythmic sensory stimulation (auditory, visual) on gait in Parkinson's disease patients. Exp Brain Res 186: 589-601, 2008.
2. Bello O, Sanchez JA, Fernandez-del-Olmo M. Treadmill walking in Parkinson's disease patients: adaptation and generalization effect. Mov Disord 23: 1243-1249, 2008.
3. Blin O, Ferrandez AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci 103: 51-54, 1991.
4. Blin O, Ferrandez AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci 98: 91-97, 1990.
5. Boonstra TA, van der Kooij H, Munneke M, Bloem BR. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol 21: 461-471, 2008.
6. Brown TG. The intrinsic factors in the active progression in the mammal. Proc R Soc Lond B Biol Sci 84: 309-319, 1911.
7. Chandler RF, Clauser CE, McConville JT, Reynolds HM, Young JW. Investigation of Inertial Properties of the Human Body (Technical Report). Dayton, OH: AMRL-TR-74-137,Wright-Patterson Air Force Base, 1975.
8. Cho C, Kudo K, Osaki Y, Kunin M, Olanow W, Cohen B, Raphan T. Effect of levodopa (LD) on pacing in Parkinson's disease (PD). Mov Disord 23, Suppl. 11: S1-S42, 2008.
9. Cho C, Osaki Y, Cohen B, Kunin M, Olanow CW, Raphan T. Effect of levodopa (LD) and deep brain stimulation (DBS) on gait dynamics in Parkinson's disease (PD). Soc Neurosc Abstr 647.10/V8, 2006a.
10. Cho C, Osaki Y, Kunin M, Cohen B, Olanow CW, Raphan T. A model-based approach for assessing parkinsonian gait and effects of levodopa and deep brain stimulation. Conf Proc IEEE Eng Med Biol Soc 2006: 1228-1231, 2006b.
11. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism: chronic treatment with L-dopa. N Engl J Med 280: 337-345, 1969.
12. Dodge R. Five types of eye movements in the horizontal meridian plane of the field of regard. Am J Physiol 8: 307-329, 1903.
13. Fahn S, Elton RL, and Members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Recent Developments in Parkinson's Disease, edited by Fahn S, Marsden CD, Calne DB, Goldstein M. Florham Park, NJ: Macmillan Healthcare Information, 1987, p. 153-163, 293-304.
14. Fernandez-del-Olmo M, Cudiero J. Temporal variability of gait in Parkinson's disease: effects of a rehabilitation programme based on rhythmic sound cues. Parkinsonism Relat Disord 11: 25-33, 2005.
15. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci 248: 173-176, 2006.
16. Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12: 302-305, 1997.
17. Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B, Paleacu D, Korczyn AD. Freezing of gait in patients with advanced Parkinson's disease. J Neural Transm 108: 53-61, 2001.
18. Grimbergen Y, Munneke M, Bloem BR. Falls in Parkinson's disease. Curr Opin Neurol 17: 405-415, 2004.
19. Hausdorff JM, Lowenthal J, Herman T, Gruendlinger L, Peretz C, Giladi N. Rhythmic auditory stimulation modulates gait variability in Parkinson's disease. Eur J Neurosci 26: 2369-2375, 2007.
20. Hirasaki E, Moore ST, Raphan T, Cohen B. Effects of walking velocity on vertical head and body movements during locomotion. Exp Brain Res 127: 117-130, 1999.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 17: 427-442, 1967.
22. Hof AL. Scaling gait data to body size. Gait Posture 4: 222-223, 1996.
23. Kirkwood BR, Sterne JAC. Essential Medical Statistics (2nd ed.). Malden, MA: Blackwell Publishing, 2003.
24. Knutsson E. An analysis of parkinsonian gait. Brain 95: 475-486, 1972.
25. Kuo AD. A simple model of bipedal walking predicts the preferred speed-step length relationship. J Biomech Eng 123: 264-269, 2001.
26. Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain 123: 2077-2090, 2000.
27. Minetti AE. Invariant aspects of human locomotion in different gravitational environments. Acta Astronaut 49: 191-198, 2001a.
28. Minetti AE. Walking on other planets. Nature 409: 467-469, 2001b.
29. Morris M, Iansek R, Matyas T, Summers J. Abnormalities in stride length-cadence relation in parkinsonian gait. Mov Disord 13: 61-69, 1998.
30. Morris M, Iansek R, McGinley J, Matyas T, Huxham F. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 20: 40-50, 2005.
31. Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry 57: 1532-1534, 1994.
32. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease: normalization strategies and underlying mechanisms. Brain 119: 551-568, 1996.
33. Murray MP. Gait as a total pattern of movement. Am J Phys Med 46: 290-333, 1967.
34. Murray MP, Spurr GB, Sepic SB, Gardner GM, Mollinger LA. Treadmill vs. floor walking: kinematics, electromyogram, and heart rate. J Appl Physiol 59: 87-91, 1985.
35. Nieuwboer A, De Weerdt W, Dom R, Nuttin B, Peeraer L, Pattyn A. Walking ability after implantation of a pallidal stimulator: analysis of plantar force distribution in patients with Parkinson's disease. Parkinsonism Relat Disord 4: 189-199, 1998.
36. Nieuwboer A, Kwakkel G, Rochester L, Jones D, van Wegen E, Willems AM, Chavret F, Hetherington V, Baker K, Lim I. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 78: 134-140, 2007.
37. Nutt JG, MC, Thompson PD. Human walking and higher-level gait disorder, particularly in the elderly. Neurology 43: 268-279, 1993.
38. Olanow CW, Stern MB, Sethi K. Scientific and clinical basis for the treatment of Parkinson's disease. Neurology 72: S1-S136, 2009.
39. Orlosvsky GN, Deliagina TG, Grillner S. Neuronal Control of Locomotion: From Mollusc to Man. New York: Oxford Univ. Press, 1999, p. 322.
40. Osaki Y, Kunin M, Cohen B, Raphan T. Three-dimensional kinematics and dynamics of the foot during walking: a model of central control mechanisms. Exp Brain Res 176: 476-496, 2007.
41. Osaki Y, Kunin M, Cohen B, Raphan T. Relative contribution of walking velocity and stepping frequency to the neural control of locomotion. Exp Brain Res 185: 121-135, 2008.
42. Papavasiliou PS, Cotzias GC, Rosal VLF, Miller ST. Treatment of Parkinsonism with N-n-propyl norapomorphine and levodopa (with or without carbidopa). Arch Neurol 35: 787-791, 1978.
43. Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci 14: 222-236, 2002.
44. Srinivasan M, Ruina A. Computer optimization of a minimal biped model discovers walking and running. Nature 439: 72-75, 2006.
45. Tang L, Cotzias GC. Modification of the actions of some neuroactive drugs by growth hormone. Arch Neurol 33: 131-134, 1976.
46. Willems AM, Nieuwboer A, Chavret F. Turning in Parkinson's disease patients and controls: the effect of auditory cues. Mov Disord 22: 1871-1878, 2007.
47. Winter DA. Biomechanical motor patterns in normal walking. J Mot Behav 15: 302-330, 1983.
48. Winter DA. Biomechanics of normal and pathological gait: implications for understanding human locomotor control. J Mot Behav 21: 337-355, 1989.
49. Winter DA, Rogers MW. Foot trajectory in human gait: a precise and multifactorial motor control task. Phys Ther 72: 45-56, 1992.
50. Xiang Y, John P, Yakushin SB, Kunin M, Raphan T, Cohen B. Dynamics of quadrupedal locomotion of monkeys: implications for central control. Exp Brain Res 177: 551-572, 2007.
51. Yahr MD, Duvoisin C, Schear MJ, Barrett RE, Hoehn MM. Treatment of parkinsonism with levodopa. Arch Neurol 21: 343-354, 1969.